Not yet reviewed — this article is pending editorial review by Lyrea.
Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
K-2c-I
βk-2C-I is a novel psychoactive substance whose nomenclature indicates it is the beta-keto analogue of 2C-I, a substituted phenethylamine psychedelic. Virtually no formal research or documentation exists regarding its pharmacology, subjective effects, toxicity, or safety profile. Due to the extreme scarcity of available data, this substance should be approached with significant caution, and thorough harm reduction practices are strongly encouraged for anyone who encounters it.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
K-2C-I produces a stimulating psychedelic experience broadly in line with its parent compound 2C-I, combining euphoria, empathic warmth, and insight with brightened colors and visuals that appear with eyes both open and closed. Perception is noticeably altered and the sense of self may soften, though the state can also tip into confusion. Mental and physical stimulation run throughout the experience and can persist as difficulty sleeping afterward.
Physical
The body load is stimulating and somewhat restless, with decreased appetite, dilated pupils, muscle tension, alternating sweating and chills, and difficulty sleeping.
Stimulation
Cognitive
The headspace is euphoric and empathic, with a capacity for insight and a mild softening of ego boundaries; confusion can also occur.
Emotional
Visual
Visual effects include brightened colors alongside closed- and open-eye visuals.
Tactile
See also: Psychedelic Intensity Scale, Effects of psychedelics (visual, cognitive, miscellaneous)
Pharmacology
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Psychosis Risk
The provided effects list includes psychedelic visuals, changes in perception, confusion, restlessness, and insomnia. Persistent psychosis is not established by the available reports.
History & Culture
Legality
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the K-2c-I article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.